Shreeram Agharkar serves as Executive at RELMADA THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Shreeram Agharkar has executed 3 insider transactions totaling $4.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 31, 2015 involved purchasing 400 shares valued at $1.0K.
Shreeram Agharkar currently holds 5,759 shares of RELMADA THERAPEUTICS, INC. (RLMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shreeram Agharkar has been a net buyer of RLMD stock. They have purchased $4.8K and sold $0 worth of shares.
Shreeram Agharkar's most recent insider trade was on Dec 31, 2015, when they purchased 400 shares at $2.50 per share.
Get notified when new Form 4 filings are submitted
| $3.25 |
| Discretionary |
| Dec 16, 2015 | RLMD | $3.5K | Purchase | 1,000 | $3.45 | Discretionary |